Search Results

Business

Minerva Biotechnologies Announces CellSystems as European Distributor of AlphaSTEM™, Naïve Stem Cell Culture System

Minerva Biotechnologies Corporation, a leading cancer immunotherapy and regenerative medicine company, announces European distribution agreement with CellSystems Biotechnologie Vertrieb a major European life science supplier, for AlphaSTEM™ Naïve Stem Cell Culture System.

February 26, 2018

·

2 min read

Business

Pharmefex, Sync.MD and X-CELLSYSTEM Form ImmuID Alliance

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

April 14, 2020

·

4 min read

Press Releases

OMass Therapeutics Appoints Jonathan Montagu as Chair of the Board of Directors

January 28, 2026

·

3 min read

BioForest

Pharmefex, Sync.MD and X-CELLSYSTEM Form ImmuID Alliance to Rapidly and Safely Open Our Country

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

April 14, 2020

·

4 min read

Deals

Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market

Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a

September 22, 2020

·

4 min read

Jennewein Biotechnologie Develops New Fermentation Technology for Human Milk Oligosaccharides and Expands its Product Portfolio

Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis approach for the production of human milk oligosaccharides (HMOs).

September 19, 2018

·

2 min read

Business

International Stem Cell Corporation Opens European Distribution Channel, Signs Contract with CellSystems Biotechnologie Vertrieb

September 5, 2007

·

1 min read

Press Releases

OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease

September 2, 2025

·

3 min read

Deals

Jennewein Biotechnologie GmbH Acquires Arthus Mineralsprings Bad Hönningen to Build a New Integrated Fermentation and Recovery Plant for Human Milk Oligosaccharides

RHEINBREITBACH, Germany, /PRNewswire/ -- Jennewein Biotechnologie GmbH announces that it has acquired the former facilities of Arthus Mineralspring Company in Bad Hönningen (Rhineland-Palatine) in order to expand the production of human milk oligosaccharides (HMOs).

October 8, 2018

·

1 min read

Business

Jennewein Biotechnologie to Build New R&D Centre for Synthetic Organisms and Microbiome Research in Bonn, Germany

Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Strasse, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms.

July 5, 2018

·

4 min read